Vyleesi carries cardiovascular cautions, a dosing-frequency limit (no more than one dose in 24 hours, and no more than eight per month), warnings about transient blood-pressure elevation, focal hyperpigmentation, and reduced efficacy or tolerability concerns with certain uses
GR can perform its enzymatic activity in the cytoplasm, but also in the ER and within lysosomes, mitochondria and the nucleus
No strong human trials affirm enhanced sperm count, motility, or morphology
Maestri A, De Pasquale Ceratti A, Cundari S, et al
The mechanism by which B12 deficiency distorts HbA1c centres on altered red blood cell turnover and erythropoiesis